Page last updated: 2024-10-28

gr 89696 and Carotid Artery Diseases

gr 89696 has been researched along with Carotid Artery Diseases in 1 studies

GR 89696: a potent & selective kappa opioid receptor agonist; RN given refers to (E)-2-butenedioate(1:1); RN for parent cpd not available 11/92; GR 103545 is the (R)-isomer

Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.

Research Excerpts

ExcerptRelevanceReference
" In these experiments GR89696 was dosed 5 min, 4, 8, 12, 16, 20 and 24 h after occlusion on the first day and then three times daily for the next three days."1.28Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist. ( Birch, PJ; Hayes, AG; Hayward, NJ; Judd, DB; Naylor, A; Rogers, H; Scopes, DI; Tyers, MB, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birch, PJ1
Rogers, H1
Hayes, AG1
Hayward, NJ1
Tyers, MB1
Scopes, DI1
Naylor, A1
Judd, DB1

Other Studies

1 other study available for gr 89696 and Carotid Artery Diseases

ArticleYear
Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.
    British journal of pharmacology, 1991, Volume: 103, Issue:3

    Topics: Animals; Brain Ischemia; Carotid Artery Diseases; Dizocilpine Maleate; Dose-Response Relationship, D

1991